ClinConnect ClinConnect Logo
Search / Trial NCT02212054

A Trial on Treatments of Hirschsprung Allied Disease

Launched by TONGJI HOSPITAL · Aug 6, 2014

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two different ways to help children with Hirschsprung allied disease who have trouble with constipation. The researchers want to find out if treating the condition with medication and other non-surgical methods (called conservative treatment) is as effective as surgery in improving constipation symptoms. The trial is currently looking for participants, including children aged 1 to 14 years who experience hard stools less than twice a week and have a specific scoring system result that indicates they might benefit from this study.

To be eligible for the trial, children must not have functional constipation and need to meet certain scoring criteria. Participants will undergo evaluations to determine if they qualify, and those who do will be part of the study comparing the two treatment options. This is a chance for families to contribute to important research that could improve treatment for children dealing with these challenging symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • hard or firm stools for twice or less per week
  • a predicting score of less than 5 refer to literature: Wu, X.J., et al., A new diagnostic scoring system to differentiate Hirschsprung's disease from Hirschsprung's disease-allied disorders in patients with suspected intestinal dysganglionosis. Int J Colorectal Dis, 2013. 28(5): p. 689-96
  • Exclusion Criteria:
  • functional constipation
  • a predicting score of more than 5 refer to literature: Wu, X.J., et al., A new diagnostic scoring system to differentiate Hirschsprung's disease from Hirschsprung's disease-allied disorders in patients with suspected intestinal dysganglionosis. Int J Colorectal Dis, 2013. 28(5): p. 689-96

About Tongji Hospital

Tongji Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology, is a leading medical institution in China dedicated to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary team of experts, Tongji Hospital focuses on translating scientific discoveries into effective treatments and therapies. The hospital is committed to enhancing patient care by conducting rigorous clinical trials that adhere to the highest ethical and regulatory standards, fostering collaboration with both national and international research communities to drive medical advancements.

Locations

Wuhan, Hubei, China

Patients applied

0 patients applied

Trial Officials

Qi T Zhu, PhD

Principal Investigator

department of pediatric surgery

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials